NewsRoom Articles - Page 89 of 115 - CanadianCannabisWire

ThursdayNov 15, 2018 11:21 am

The Flowr Corporation (TSX.V: FLWR) Leverages Cultivation Skill and R&D Alliance to Boost Earnings Potential

The Flowr Corporation’s stock is rated as a ‘Speculative Buy’ in expectation of above-average profit margins and significant growth Flowr fulfilled orders from three provinces on-time and in-full in advance of October 17 and is preparing re-stocking shipments Investment in a 50,000 square foot cannabis R&D facility expected to keep the company on the cutting edge of cultivation productivity and quality The Flowr Corporation (TSX.V: FLWR) is a Canada-based licensed producer of premium cannabis products. The company invests heavily in its cultivation and R&D teams and facilities in order to produce premium and ultra-premium cannabis that provides a consistent consumer…

WednesdayNov 14, 2018 12:11 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Grows Stronger with Patents and Third-Party Partners

Improving the quality, taste and effectiveness of cannabis products with DehydraTECH Recently granted two new U.S. patents, with over 50 additional patent applications filed worldwide Applications span a wide range of products as the company out-licenses IP to third-party partners through a royalty model Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is using its DehydraTECH to increase the quality, taste and effectiveness of cannabis products. Lexaria’s revolutionary drug delivery platform is disrupting the way cannabidiol enters the bloodstream. Rather than relying on the traditional methods of inhalation, which has harmful lasting impact on a person’s health, DehydraTECH allows for a…

TuesdayNov 13, 2018 10:19 am

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) is “One to Watch”

The first medical cannabis incubator and accelerator financing medical cannabis, CBD and hemp companies through a debt facility Well-positioned to gain market share in the emerging cannabis market Global legal marijuana market projected to be $146.4 billion by 2025 Pursuing opportunities in emerging markets and the unique market conditions in the cannabis industry enable unique growth for the company Robust loan portfolio consisting of diverse, successful players in the cannabis industry Actively looking beyond borders and creating global companies with strong fundamentals that are ready for expansion Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) is a merchant bank…

ThursdayNov 08, 2018 9:45 am

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Private Placement Raises Gross Proceeds of $1.5M; Funds Allocated for Canadian Lab, R&D

Increased size of non-brokered private placement raises gross proceeds of $1,515,440, to be used to fund construction of new Canadian lab, LXRP's R&D and general corporate purposes LXRP has received two new U.S. patents related to cannabinoid infused beverage compositions using DehydraTECH; the company is a drug delivery innovator The company has expanded its IP portfolio, giving it a total of 10 patents in its first family in the U.S. and Australia; it has 50 patent applications globally and out-licenses its technology Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has raised, in a non-brokered private placement, a total of $1,515,440.…

WednesdayNov 07, 2018 12:31 pm

Plus Products Inc. (CSE: PLUS) is “One to Watch”

California consumers purchased $180 million worth of cannabis-infused food and drinks in 2017 – 10% of the state’s total marijuana sales – with that percentage rising to 18% in February 2018. Cannabis-infused gummies have a much wider appeal since they are less conspicuous to consume and provide a smoke-free experience Advances in technology allow manufacturers of cannabis-infused edibles to tweak concentrations of THC and CBD The Specialty Food Association has named cannabis edibles as one of the Top 10 food trends of 2018 Plus Products Inc. (CSE: PLUS) is a branded cannabis-infused products manufacturer of edibles created to support a…

TuesdayNov 06, 2018 10:49 am

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) (FRA: 53S1) is “One to Watch”

Canada’s only licensed cannabis producer principally focused on premium brands and products with coast-to-coast distribution Current annual production run rate of 13,333 kg, ramping up to estimated 50,000 kg full capacity in 2019 Recently signed 1-year CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY) to support medical cannabis patients Commands premium wholesale prices up to one-third higher than other brands Supply agreements in place with six Canadian provinces Recently uplisted to OTCQX market in the U.S under ticker symbol SPRWF In September 2018 announced record fiscal year and Q4 results Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) (FRA:…

FridayNov 02, 2018 11:31 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Focusing on its New Subsidiaries and Intellectual Property

Lexaria has its patented DehydraTECH drug delivery platform The company’s technology is a complementary layer that works with the other research being done on cannabinoids Lexaria has a robust IP portfolio and four new subsidiary companies A drug delivery platform pioneer, Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has developed and out-licenses its DehydraTECH technology. The company’s technology changes the way in which edible cannabinoids absorb into the body. The DehydraTECH drug delivery platform is patented for cannabidiol and all other non-psychoactive cannabinoids and enables the transportation of bioactive substances via oral ingestion. A research-driven enterprise, Lexaria Bioscience is based…

ThursdayNov 01, 2018 11:42 am

The Flowr Corporation (TSX.V: FLWR) is Coming into Full Bloom

Company fulfilled purchase orders from British Columbia, Nova Scotia and Ontario in-full and on-time for October 17 adult-use market opening and is preparing re-stocking shipments following sell-outs Flowr launched new Ace Valley brand in partnership with the team behind the highly successful Ace Hill Beer Company broke ground on a first-of-its-kind, 50,000 square foot R&D facility funded by its exclusive R&D partner, the Hawthorne Gardening Division of the Scotts Miracle-Gro Company. Facility is expected to open in the summer of 2019 alongside Flowr’s cultivation complex in Kelowna, BC October has been a busy month for Canadian cannabis companies, perhaps none…

WednesdayOct 31, 2018 11:18 am

Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) Comments on DEA’s Removal of Cannabidiol from Schedule 1

Phivida’s vision is to help lessen the world’s dependence on pharmaceuticals The company comprises two main brands Phivida recently talked about the removal of CBD from Schedule 1 of the Controlled Substances Act Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) is a premium functional food and beverage company. Its focus is whole plant nutrition and natural ingredients. As a result, it infuses organic active hemp extract into an array of premium foods, beverages and clinical products. Phivida’s corporate mission is to help reduce the world’s dependence on pharmaceuticals and provide healthy food and beverage choices. Phivida is headquartered in Vancouver,…

MondayOct 29, 2018 1:17 pm

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Advances Expansion Plans through HemPoland Acquisition

The acquisition of HemPoland accelerates opportunities for growth in the European market as part of TGOD’s international strategy The company has received medical sales licensing for its Ancaster, Ontario, facilities – one of many sites where TGOD aims to cultivate cannabis products The company recently closed a $75 million bought deal financing to further its expansion plans in Latin America and Europe Cannabis company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) has announced the acquisition of HemPoland and the closing of a new bought deal financing, part of several recent developments demonstrating the company’s strong commitment to…

News and Publishing Service for Cannabis Related, Canadian Companies

Contact us: 512.354.7000